Siddhartha Mitra

Siddhartha Mitra, MD, PhD, currently serves as the Chief Medical Officer at Trishula Therapeutics, Inc., a position held since June 2023. Prior to this role, Siddhartha Mitra was Vice President of Clinical Development at Arcus Biosciences from June 2021 to June 2023, and earlier held the position of Executive Director, Clinical Development at Five Prime Therapeutics from September 2018 to June 2021. Siddhartha Mitra's extensive clinical development experience includes leading oncology therapeutics initiatives for solid tumors and hematologic malignancies at Gilead Sciences, where responsibilities encompassed BTK inhibitor development and CAR T-cell therapy contributions. Academic training includes a Doctor of Medicine and a Doctor of Philosophy in Biomedical Sciences from the University of California, San Francisco, and a Bachelor of Science in Biological and Biomedical Sciences from Stanford University.